Annual revenue:
$6.17M-$11.97M(-65.98%)Summary
- As of today (August 20, 2025), ABUS annual revenue is $6.17 million, with the most recent change of -$11.97 million (-65.98%) on December 31, 2024.
- During the last 3 years, ABUS annual revenue has fallen by -$4.82 million (-43.84%).
- ABUS annual revenue is now -84.18% below its all-time high of $39.02 million, reached on December 31, 2022.
Performance
ABUS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$10.74M+$8.97M(+508.79%)Summary
- As of today (August 20, 2025), ABUS quarterly revenue is $10.74 million, with the most recent change of +$8.97 million (+508.79%) on June 30, 2025.
- Over the past year, ABUS quarterly revenue has increased by +$9.01 million (+522.19%).
- ABUS quarterly revenue is now -24.59% below its all-time high of $14.24 million, reached on June 30, 2022.
Performance
ABUS Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$15.42M+$9.01M(+140.76%)Summary
- As of today (August 20, 2025), ABUS TTM revenue is $15.42 million, with the most recent change of +$9.01 million (+140.76%) on June 30, 2025.
- Over the past year, ABUS TTM revenue has increased by +$5.36 million (+53.23%).
- ABUS TTM revenue is now -60.49% below its all-time high of $39.02 million, reached on December 31, 2022.
Performance
ABUS TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ABUS Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -66.0% | +522.2% | +53.2% |
| 3 y3 years | -43.8% | -24.6% | -53.8% |
| 5 y5 years | +2.7% | +609.3% | +100.6% |
ABUS Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -84.2% | at low | -24.6% | +702.0% | -60.5% | +149.8% |
| 5 y | 5-year | -84.2% | +2.7% | -24.6% | +702.0% | -60.5% | +150.8% |
| alltime | all time | -84.2% | >+9999.0% | -24.6% | +5607.2% | -60.5% | >+9999.0% |
ABUS Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $10.74M(+508.8%) | $15.42M(+140.8%) |
| Mar 2025 | - | $1.76M(+12.1%) | $6.40M(+3.8%) |
| Dec 2024 | $6.17M(-66.0%) | $1.57M(+17.6%) | $6.17M(-8.5%) |
| Sep 2024 | - | $1.34M(-22.4%) | $6.74M(-33.0%) |
| Jun 2024 | - | $1.73M(+12.7%) | $10.06M(-22.5%) |
| Mar 2024 | - | $1.53M(-28.6%) | $12.99M(-28.4%) |
| Dec 2023 | $18.14M(-53.5%) | $2.15M(-54.0%) | $18.14M(-18.4%) |
| Sep 2023 | - | $4.66M(+0.2%) | $22.24M(-5.5%) |
| Jun 2023 | - | $4.65M(-30.4%) | $23.54M(-29.0%) |
| Mar 2023 | - | $6.69M(+7.1%) | $33.13M(-15.1%) |
| Dec 2022 | $39.02M(+255.1%) | $6.25M(+4.9%) | $39.02M(+8.4%) |
| Sep 2022 | - | $5.95M(-58.2%) | $35.98M(+7.8%) |
| Jun 2022 | - | $14.24M(+13.2%) | $33.37M(+55.5%) |
| Mar 2022 | - | $12.58M(+292.4%) | $21.46M(+95.3%) |
| Dec 2021 | $10.99M(+58.9%) | $3.21M(-4.0%) | $10.99M(+8.1%) |
| Sep 2021 | - | $3.34M(+43.4%) | $10.17M(+21.8%) |
| Jun 2021 | - | $2.33M(+10.2%) | $8.35M(+10.8%) |
| Mar 2021 | - | $2.11M(-11.4%) | $7.54M(+9.0%) |
| Dec 2020 | $6.91M(+15.0%) | $2.39M(+56.7%) | $6.91M(+12.5%) |
| Sep 2020 | - | $1.52M(+0.6%) | $6.15M(-20.0%) |
| Jun 2020 | - | $1.51M(+1.5%) | $7.68M(+12.6%) |
| Mar 2020 | - | $1.49M(-7.8%) | $6.82M(+13.5%) |
| Dec 2019 | $6.01M(+1.1%) | $1.62M(-47.1%) | $6.01M(-1.0%) |
| Sep 2019 | - | $3.06M(+368.8%) | $6.07M(+32.1%) |
| Jun 2019 | - | $653.00K(-3.8%) | $4.60M(-11.4%) |
| Mar 2019 | - | $679.00K(-59.5%) | $5.19M(-12.7%) |
| Dec 2018 | $5.95M(-44.4%) | $1.68M(+5.7%) | $5.95M(-12.6%) |
| Sep 2018 | - | $1.59M(+27.6%) | $6.80M(-43.8%) |
| Jun 2018 | - | $1.24M(-13.4%) | $12.11M(+1.7%) |
| Mar 2018 | - | $1.44M(-43.3%) | $11.90M(+11.2%) |
| Dec 2017 | $10.70M(+617.6%) | $2.53M(-63.2%) | $10.70M(+34.2%) |
| Sep 2017 | - | $6.89M(+563.3%) | $7.97M(+330.2%) |
| Jun 2017 | - | $1.04M(+342.1%) | $1.85M(+65.0%) |
| Mar 2017 | - | $235.00K(-220.5%) | $1.12M(-24.7%) |
| Dec 2016 | $1.49M(-94.0%) | -$195.00K(-125.2%) | $1.49M(-89.6%) |
| Sep 2016 | - | $774.00K(+150.5%) | $14.37M(-18.6%) |
| Jun 2016 | - | $309.00K(-48.8%) | $17.66M(-15.1%) |
| Mar 2016 | - | $603.00K(-95.2%) | $20.79M(-16.4%) |
| Dec 2015 | $24.87M(+66.3%) | $12.69M(+212.1%) | $24.87M(+50.4%) |
| Sep 2015 | - | $4.07M(+18.2%) | $16.54M(-1.8%) |
| Jun 2015 | - | $3.44M(-26.5%) | $16.83M(+10.7%) |
| Mar 2015 | - | $4.68M(+7.6%) | $15.21M(+1.7%) |
| Dec 2014 | $14.95M(-3.3%) | $4.35M(-0.3%) | $14.95M(-17.5%) |
| Sep 2014 | - | $4.36M(+140.9%) | $18.13M(+8.5%) |
| Jun 2014 | - | $1.81M(-59.1%) | $16.70M(-5.9%) |
| Mar 2014 | - | $4.43M(-41.1%) | $17.75M(+14.5%) |
| Dec 2013 | $15.46M(+9.6%) | $7.53M(+156.3%) | $15.50M(+30.4%) |
| Sep 2013 | - | $2.94M(+2.6%) | $11.89M(-1.0%) |
| Jun 2013 | - | $2.86M(+31.4%) | $12.01M(-5.7%) |
| Mar 2013 | - | $2.18M(-44.3%) | $12.73M(-9.8%) |
| Dec 2012 | $14.11M(-16.1%) | $3.91M(+27.7%) | $14.11M(+1.9%) |
| Sep 2012 | - | $3.06M(-14.5%) | $13.85M(-7.9%) |
| Jun 2012 | - | $3.58M(+0.6%) | $15.03M(-6.1%) |
| Mar 2012 | - | $3.56M(-2.5%) | $16.00M(-5.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $16.83M(-18.8%) | $3.65M(-14.0%) | $16.85M(-12.8%) |
| Sep 2011 | - | $4.24M(-6.8%) | $19.32M(-22.9%) |
| Jun 2011 | - | $4.55M(+3.3%) | $25.06M(+10.1%) |
| Mar 2011 | - | $4.41M(-27.9%) | $22.76M(+9.8%) |
| Dec 2010 | $20.73M(+63.9%) | $6.12M(-38.8%) | $20.73M(+9.8%) |
| Sep 2010 | - | $9.99M(+343.5%) | $18.87M(+59.0%) |
| Jun 2010 | - | $2.25M(-5.0%) | $11.87M(-7.7%) |
| Mar 2010 | - | $2.37M(-44.3%) | $12.85M(+0.5%) |
| Dec 2009 | $12.65M(+15.1%) | $4.26M(+42.7%) | $12.79M(+15.4%) |
| Sep 2009 | - | $2.98M(-7.8%) | $11.08M(-8.8%) |
| Jun 2009 | - | $3.24M(+40.0%) | $12.15M(+6.5%) |
| Mar 2009 | - | $2.31M(-9.2%) | $11.41M(+3.8%) |
| Dec 2008 | $10.99M(-25.2%) | $2.55M(-37.1%) | $10.99M(-13.7%) |
| Sep 2008 | - | $4.05M(+62.2%) | $12.73M(-10.0%) |
| Jun 2008 | - | $2.50M(+31.5%) | $14.15M(-1.5%) |
| Mar 2008 | - | $1.90M(-55.7%) | $14.36M(-3.7%) |
| Dec 2007 | $14.69M(+5.1%) | $4.29M(-21.5%) | $14.92M(+14.2%) |
| Sep 2007 | - | $5.46M(+101.2%) | $13.06M(-5.7%) |
| Jun 2007 | - | $2.71M(+10.7%) | $13.85M(-16.3%) |
| Mar 2007 | - | $2.45M(+0.8%) | $16.54M(+17.3%) |
| Dec 2006 | $13.98M(+9.8%) | - | - |
| Dec 2006 | - | $2.43M(-61.1%) | $14.10M(+20.8%) |
| Sep 2006 | - | $6.25M(+15.5%) | $11.67M(+115.3%) |
| Jun 2006 | - | $5.41M(>+9900.0%) | $5.42M(>+9900.0%) |
| Mar 2006 | - | $9800.00(>+9900.0%) | $9800.00(-99.9%) |
| Dec 2005 | $12.74M(+13.3%) | - | - |
| Dec 2005 | - | $0.00(0.0%) | $12.59M(-22.0%) |
| Sep 2005 | - | $0.00(0.0%) | $16.13M(-13.6%) |
| Jun 2005 | - | $0.00(-100.0%) | $18.67M(-11.6%) |
| Mar 2005 | - | $12.59M(+254.9%) | $21.12M(+86.9%) |
| Dec 2004 | $11.24M(+344.3%) | - | - |
| Dec 2004 | - | $3.55M(+39.6%) | $11.30M(+42.4%) |
| Sep 2004 | - | $2.54M(+3.7%) | $7.94M(+32.4%) |
| Jun 2004 | - | $2.45M(-11.5%) | $6.00M(+65.1%) |
| Mar 2004 | - | $2.77M(+1417.4%) | $3.63M(+49.7%) |
| Dec 2003 | $2.53M(-50.2%) | - | - |
| Dec 2003 | - | $182.40K(-69.5%) | $2.43M(-14.1%) |
| Sep 2003 | - | $597.10K(+601.6%) | $2.82M(+12.8%) |
| Jun 2003 | - | $85.10K(-94.6%) | $2.50M(-53.1%) |
| Mar 2003 | - | $1.56M(+169.5%) | $5.34M(+4.8%) |
| Dec 2002 | $5.09M(+43.0%) | - | - |
| Dec 2002 | - | $579.70K(+110.2%) | $5.09M(-10.2%) |
| Sep 2002 | - | $275.80K(-90.6%) | $5.67M(-17.1%) |
| Jun 2002 | - | $2.92M(+121.7%) | $6.84M(+35.8%) |
| Mar 2002 | - | $1.32M(+14.0%) | $5.03M(+29.3%) |
| Dec 2001 | $3.56M(+7232.2%) | - | - |
| Dec 2001 | - | $1.16M(-19.9%) | $3.89M(+42.2%) |
| Sep 2001 | - | $1.44M(+29.0%) | $2.74M(+111.4%) |
| Jun 2001 | - | $1.12M(+531.5%) | $1.29M(+631.5%) |
| Mar 2001 | - | $177.00K | $177.00K |
| Dec 2000 | $48.50K(-91.2%) | - | - |
| Dec 1999 | $553.70K(-3.4%) | - | - |
| Dec 1998 | $573.20K(+98.9%) | - | - |
| Dec 1997 | $288.20K | - | - |
FAQ
- What is Arbutus Biopharma Corporation annual revenue?
- What is the all time high annual revenue for Arbutus Biopharma Corporation?
- What is Arbutus Biopharma Corporation annual revenue year-on-year change?
- What is Arbutus Biopharma Corporation quarterly revenue?
- What is the all time high quarterly revenue for Arbutus Biopharma Corporation?
- What is Arbutus Biopharma Corporation quarterly revenue year-on-year change?
- What is Arbutus Biopharma Corporation TTM revenue?
- What is the all time high TTM revenue for Arbutus Biopharma Corporation?
- What is Arbutus Biopharma Corporation TTM revenue year-on-year change?
What is Arbutus Biopharma Corporation annual revenue?
The current annual revenue of ABUS is $6.17M
What is the all time high annual revenue for Arbutus Biopharma Corporation?
Arbutus Biopharma Corporation all-time high annual revenue is $39.02M
What is Arbutus Biopharma Corporation annual revenue year-on-year change?
Over the past year, ABUS annual revenue has changed by -$11.97M (-65.98%)
What is Arbutus Biopharma Corporation quarterly revenue?
The current quarterly revenue of ABUS is $10.74M
What is the all time high quarterly revenue for Arbutus Biopharma Corporation?
Arbutus Biopharma Corporation all-time high quarterly revenue is $14.24M
What is Arbutus Biopharma Corporation quarterly revenue year-on-year change?
Over the past year, ABUS quarterly revenue has changed by +$9.01M (+522.19%)
What is Arbutus Biopharma Corporation TTM revenue?
The current TTM revenue of ABUS is $15.42M
What is the all time high TTM revenue for Arbutus Biopharma Corporation?
Arbutus Biopharma Corporation all-time high TTM revenue is $39.02M
What is Arbutus Biopharma Corporation TTM revenue year-on-year change?
Over the past year, ABUS TTM revenue has changed by +$5.36M (+53.23%)